These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1176 related items for PubMed ID: 15652415

  • 1. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 3. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 4. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M.
    Brain; 2005 Nov 15; 128(Pt 11):2689-704. PubMed ID: 16123145
    [Abstract] [Full Text] [Related]

  • 5. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
    Wiesemann E, Deb M, Trebst C, Hemmer B, Stangel M, Windhagen A.
    Mult Scler; 2008 Mar 15; 14(2):166-76. PubMed ID: 17942524
    [Abstract] [Full Text] [Related]

  • 6. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 15; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 7. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May 15; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 8. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I, Sutter G, Huber C, Seliger B.
    Cancer Res; 2003 Jul 15; 63(14):4107-11. PubMed ID: 12874014
    [Abstract] [Full Text] [Related]

  • 9. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.
    Eur J Immunol; 2009 Sep 15; 39(9):2525-36. PubMed ID: 19670379
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cells bearing HLA-G inhibit T-Cell activation in type 1 diabetes.
    Abediankenari S, Eslami MB, Sarrafnejad A, Mohseni M, Larijani B.
    Iran J Allergy Asthma Immunol; 2007 Mar 15; 6(1):1-7. PubMed ID: 17303922
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG.
    Mult Scler; 2010 Jan 15; 16(1):30-8. PubMed ID: 20007427
    [Abstract] [Full Text] [Related]

  • 12. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.
    Scand J Immunol; 2006 Aug 15; 64(2):155-63. PubMed ID: 16867161
    [Abstract] [Full Text] [Related]

  • 13. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 14. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
    López AS, Alegre E, LeMaoult J, Carosella E, González A.
    Mol Immunol; 2006 Jul 15; 43(14):2151-60. PubMed ID: 16490253
    [Abstract] [Full Text] [Related]

  • 15. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
    Yang D, Wang H, Ni B, He Y, Li J, Tang Y, Fu X, Wang Q, Xu G, Li K, Yang Z, Wu Y.
    Mol Immunol; 2009 Apr 15; 46(7):1432-42. PubMed ID: 19200602
    [Abstract] [Full Text] [Related]

  • 16. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S, Gonzalez A, Gonzalez AS, Carosella ED, Rouas-Freiss N.
    Immunology; 2005 Nov 15; 116(3):297-307. PubMed ID: 16236119
    [Abstract] [Full Text] [Related]

  • 17. B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.
    Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S.
    J Immunol; 2011 Apr 01; 186(7):4518-26. PubMed ID: 21368231
    [Abstract] [Full Text] [Related]

  • 18. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F.
    Mult Scler; 2008 Jun 01; 14(5):622-30. PubMed ID: 18424480
    [Abstract] [Full Text] [Related]

  • 19. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P.
    Ann Neurol; 1998 Jul 01; 44(1):27-34. PubMed ID: 9667590
    [Abstract] [Full Text] [Related]

  • 20. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D.
    Neuroimmunomodulation; 2005 Jul 01; 12(4):220-34. PubMed ID: 15990453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.